SmartBrief > Health Care > FDLI SmartBrief > Latest Industry Press Releases

Press Releases


U.S. Food and Drug Administration Approves ABILIFY (aripiprazole) for the Treatment of Irritability Associated with Autistic Disorder in Pediatric Patients (Ages 6 to 17 Years)

Business Wire | 19 hours 15 minutes ago

Bristol-Myers Squibb Company (NYSE: BMY) and Otsuka Pharmaceutical Co., Ltd. announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for ABILIFY® (aripiprazole) for the treatment of irritability associated with autistic disorder in pediatric patients ages 6 to 17 years, including symptoms of aggression towards others, deliberate self-injuriousness, temper tantrums, and quickly changing moods.... (more)


NUCRYST Announces Special Meeting of Shareholders

PRNewswire | 19 hours 45 minutes ago

PRINCETON, NJ, Nov. 20 /PRNewswire-FirstCall/ - NUCRYST Pharmaceuticals Corp. announced today that a Special Meeting of Shareholders will be held on Monday, December 21, 2009. The purpose of the Meeting is to consider approval of two special resolutions. The first special resolution is to approve and authorize the sale of all or substantially all of the assets of NUCRYST, substantially on the terms provided for in the asset purchase agreement dated November 10, 2009 among the NUCRYST Pharmace...... (more)


Zacks Analyst Blog Highlights: Aetna Inc., UnitedHealth Group Inc., WellPoint Inc., Assurant Inc. and Cigna Corp

Business Wire | 21 hours 15 minutes ago

Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Aetna Inc. (NYSE: AET), UnitedHealth Group Inc. (NYSE: UNH), WellPoint Inc. (NYSE: WLP), Assurant Inc. (NYSE: AIZ) and Cigna Corp (NYSE: CI).... (more)


Lannett Reauthorizes Stock Repurchase Program

Business Wire | 23 hours 15 minutes ago

Lannett Company, Inc. (NYSE AMEX: LCI) today announced that its Board of Directors has approved a reauthorization of the stock repurchase program. Under the program, the company is authorized to repurchase up to $5 million of Lannett’s outstanding common stock from time to time in open market and privately negotiated transactions.... (more)


Reportlinker Adds Power Wheelchair Market Shares, Strategies, and Forecasts, Worldwide, 2009 to 2015

PRNewswire | 1 day 1 hour 45 minutes ago

... (more)


Reportlinker Adds Medical Specialty Bags - Global Market Trends

PRNewswire | 1 day 3 hours 15 minutes ago

... (more)


Reportlinker Adds Stethoscopes - A Worldwide Market Intelligence Report

PRNewswire | 1 day 3 hours 15 minutes ago

... (more)


AstraZeneca and the Philadelphia Department of Public Health Provide Free Medicines to Pennsylvania's Uninsured

PRNewswire | 1 day 3 hours 44 minutes ago

... (more)


Biotel Announced Profitable First Quarter Ended September 30, 2009

PRNewswire | 1 day 3 hours 45 minutes ago

... (more)




 1  2  3  4  5  6  7  8   Next >

105 Press Releases  |   RSS Feed



Sign up for FDLI SmartBrief



Designed specifically for professionals involved in the food and drug industry, FDLI SmartBrief is a FREE daily e-mail newsletter. It provides the latest need-to-know news and industry information that maximizes your time, giving you an edge over your competition. Learn more

Latest Blog Postsview more


exambible---IT Certification center
Science Blog


New Wound Dressing with Drug Releasing Fibers
BioTech Weblog, The


Smartphone app illuminates power consumption
Science Blog


Saving the single cysteine: New antioxidant system found
Science Blog

Job Listingsview more


Companies in the news